⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BCRX News
BioCryst Pharmaceuticals Inc
B-cell Inhibitors Market for Non-Oncology Diseases, 2026-2035 Industry Trends and Global Forecasts - Growing Prevalence of Autoimmune Disorders and Hematologic Cancers Drives Rapid Advancement
globenewswire.com
IBRX
BCRX
Avalyn Appoints Biopharmaceutical Industry Leader Kate Haviland to Board of Directors
globenewswire.com
BCRX
SRPT
BTAI
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BCRX
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
BCRX
Form 8-K
sec.gov
BCRX
BioCryst Reports Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
BCRX
AM Best Affirms Credit Ratings of Compañía Internacional de Seguros, S.A.
businesswire.com
BCRX
AM Best Affirms Credit Ratings of Compañía Internacional de Seguros, S.A.
businesswire.com
BCRX
BioCryst to Present at Upcoming Investor Conference
globenewswire.com
BCRX
BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting
globenewswire.com
BCRX